Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

563
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
563
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

591
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
591
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

3.7K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
3.7K
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

477
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
477
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

672
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
672
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

14.9K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
14.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Beyond headache: Cognitive improvement in patients with migraine responding to anti-CGRP monoclonal antibodies or botulinum toxin.

Cephalalgia : an international journal of headache·2026
Same author

Associations between breathlessness and individuals' satisfaction with sexual life: a nationally representative internet survey.

BMJ open respiratory research·2026
Same author

Breast cancer survivor's sexual health unmet supportive care needs: a mixed-methods study.

Journal of cancer survivorship : research and practice·2026
Same author

Sensory Representation of Neural Networks Using Sound and Color for Medical Imaging Segmentation.

Journal of imaging·2025
Same author

Diminishing activities of daily living as severity of chronic breathlessness worsens: a national, cross-sectional survey.

BMJ open respiratory research·2025
Same author

Don't ask, don't tell (DADT): under-recognition of breathlessness in clinical care-a national survey.

BMJ open respiratory research·2025

Related Experiment Video

Updated: Nov 22, 2025

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
08:51

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Published on: September 20, 2024

1.8K

Data Mining for Cardiovascular Disease Prediction.

Bárbara Martins1, Diana Ferreira2, Cristiana Neto2

  • 1University of Minho, Campus of Gualtar, Braga, 4710, Portugal.

Journal of Medical Systems
|January 6, 2021
PubMed
Summary

Data mining techniques can predict cardiovascular diseases (CVDs) by analyzing clinical data. Optimized Decision Trees (DT) showed the most promising results for early CVD detection.

Keywords:
CRISP-DMCardiovascular diseaseClassificationData miningDecision support systemsHealth information systems

More Related Videos

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.8K
Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

909

Related Experiment Videos

Last Updated: Nov 22, 2025

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
08:51

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Published on: September 20, 2024

1.8K
Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.8K
Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

909

Area of Science:

  • Computational intelligence
  • Medical informatics
  • Data science

Background:

  • Cardiovascular diseases (CVDs) are a leading cause of global mortality and disability.
  • Early identification of individuals at high risk for CVD is crucial for preventing premature death.
  • Clinical data analysis using computational methods offers potential for improved CVD prediction.

Purpose of the Study:

  • To apply Data Mining Techniques (DMTs) to clinical data for predicting cardiovascular diseases (CVDs).
  • To evaluate the performance of various classification models in CVD risk assessment.

Main Methods:

  • Utilized the CRossIndustry Standard Process for Data Mining (CRISP-DM) methodology.
  • Applied five classifiers: Decision Tree (DT), Optimized DT, RIPPER (RI), Random Forest (RF), and Deep Learning (DL).
  • Developed models using RapidMiner and WEKA tools, analyzing accuracy, precision, sensitivity, and specificity.

Main Results:

  • The Optimized DT model demonstrated superior performance across all evaluation metrics.
  • Optimized DT achieved 73.54% accuracy, 75.82% precision, 68.89% sensitivity, and 78.16% specificity.
  • The Area Under the Curve (AUC) for the Optimized DT model was 0.788.

Conclusions:

  • Data mining techniques show promise for effective CVD diagnosis.
  • The Optimized DT model is a highly effective tool for predicting cardiovascular diseases.
  • Further research into DMTs can enhance early CVD detection and patient outcomes.